Evidence map›Paper›PMID 38928422›Full record

ArticleInternational journal of molecular sciences2024

Rational Approach toward COVID-19's Main Protease Inhibitors: A Hierarchical Biochemoinformatics Analysis.

Ruan S Bastos, Christiane P O de Aguiar, Jorddy N Cruz, Ryan S Ramos, Njogu M Kimani, João S N de Souza, Mariana H Chaves, Humberto F de Freitas, Samuel S R Pita, Cleydson B R Dos Santos

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Integrating Chemo- and Bioinformatics withJournal of chemical information and modeling · 2025
    Article
  2. Article
  3. Identification of Novel Progesterone Receptor (PR) Inhibitors (Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Assessing the Efficacy of Acanthoic Acid Isolated fromCurrent issues in molecular biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruan S BastosGraduate Program in Medicinal Chemistry and Molecular Modeling, Federal University of Pará, Belém 66075-110, PA, Brazil.
Christiane P O de AguiarGraduate Program in Medicinal Chemistry and Molecular Modeling, Federal University of Pará, Belém 66075-110, PA, Brazil.
Jorddy N CruzLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapa 68903-419, AP, Brazil.ORCID 0000-0003-0529-3714
Ryan S RamosLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapa 68903-419, AP, Brazil.ORCID 0000-0003-1802-1320
Njogu M KimaniDepartment of Physical Sciences, University of Embu, Embu P.O. Box 6-60100, Kenya.ORCID 0000-0002-5171-1940
João S N de SouzaChemistry Department, Federal University of Piauí, Teresina 64049-550, PI, Brazil.
Mariana H ChavesChemistry Department, Federal University of Piauí, Teresina 64049-550, PI, Brazil.
Humberto F de FreitasLaboratory of Bioinformatics and Molecular Modeling (LaBiMM), Federal University of Bahia, Av. Barão de Jeremoabo, 147, Pharmacy College, Ondina, Salvador 40170-115, BA, Brazil.ORCID 0000-0003-3040-9694
Samuel S R PitaLaboratory of Bioinformatics and Molecular Modeling (LaBiMM), Federal University of Bahia, Av. Barão de Jeremoabo, 147, Pharmacy College, Ondina, Salvador 40170-115, BA, Brazil.ORCID 0000-0003-4053-8721
Cleydson B R Dos SantosGraduate Program in Medicinal Chemistry and Molecular Modeling, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0002-0271-335X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the potential of selected compounds as inhibitors of SARS-CoV-2 M

Indexed as

Coronavirus 3C ProteasesCOVID-19 Drug TreatmentMolecular Docking SimulationMolecular Dynamics SimulationSARS-CoV-2Antiviral AgentsCOVID-19HumansHydrogen BondingLigandsProtease InhibitorsProtein BindingAntiviral AgentsCoronavirus 3C ProteasesLigandsProtease Inhibitorsbinding affinitydrug developmentmolecular dockingmolecular dynamicsSARS-CoV-2

Identifiers

PMID38928422
PMCPMC11204165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.